HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between Human Leukocyte Antigens (HLA-A, -B, and -DR) and end-stage renal disease in Kuwaiti patients awaiting transplantation.

Abstract
The number of patients with end stage renal disease (ESRD) is increasing considerably worldwide. Human Leukocyte Antigens (HLAs) are relevant for the expression of many immunological diseases and contribute to the development of different nephropathies. Therefore, we aimed from the present work to investigate the possible association between the frequency of HLA-A, -B, and -DR antigens and ESRD in Kuwaiti patients awaiting renal transplant. HLA-A, -B, and -DR typing was performed by complement-dependent cytotoxicity (CDC) method for 334 patients with ESRD awaiting renal transplantation and 191 healthy controls. The frequency of HLA-B8 antigen was significantly higher in ESRD patients (OR = 2.62, p = 0.001, pc = 0.038), and the frequency of HLA-A28, HLA-DR11 antigens was significantly higher in healthy controls (OR 0.42, p = 0.0001; pc = 0.0021, and OR = 0.44, p = 0.0007, pc = 0.01 respectively). While the HLA-B8 antigen may be a susceptibility risk factor for development of ESRD, the HLA-A28, and HLA-DR11 antigens may be protective against development of ESRD in Kuwaiti population.
AuthorsYoussef M Mosaad, Merveet Mansour, Ibrahim Al-Muzairai, Turky Al-Otabi, Mohamed Abdul-Moneam, Rajaa Al-Attiyah, Manal Shahin
JournalRenal failure (Ren Fail) Vol. 36 Issue 8 Pg. 1317-21 (Sep 2014) ISSN: 1525-6049 [Electronic] England
PMID25010329 (Publication Type: Journal Article)
Chemical References
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-DR Antigens
Topics
  • Adult
  • Female
  • HLA-A Antigens (blood)
  • HLA-B Antigens (blood)
  • HLA-DR Antigens (blood)
  • Humans
  • Kidney Failure, Chronic (blood, immunology)
  • Kidney Transplantation
  • Kuwait
  • Male
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: